The protective effect of Bifidobacterium bifidum G9-1 against mucus degradation by Akkermansia muciniphila following small intestine injury caused by a proton pump inhibitor and aspirin

References

• Pavlidis P, Bjarnason I. Aspirin induced adverse effects on the small and large intestine. Curr Pharm Des. 2015;21:5089–5093. doi:https://doi.org/10.2174/1381612821666150915110058.
   Google Scholar
• Endo H, Sakai E, Kato T, Umezawa S, Higurashi T, Ohkubo H, Nakajima A. Small bowel injury in low-dose aspirin users. J Gastroenterol. 2015;50:378–386. doi:https://doi.org/10.1007/s00535-014-1028-x.
   Google Scholar
• Smecuol E, Pinto Sanchez MI, Suarez A, Argonz JE, Sugai E, Vazquez H, Litwin N, Piazuelo E, Meddings JB, Bai JC, et al. Low-dose aspirin affects the small bowel mucosa: results of a pilot study with a multidimensional assessment. Clin Gastroenterol Hepatol. 2009;7:524–529. doi:https://doi.org/10.1016/j.cgh.2008.12.019.
   Google Scholar
• Ohira T, Iso H. Cardiovascular disease epidemiology in Asia. Circ J. 2013;77:1646–1652. doi:https://doi.org/10.1253/circj.CJ-13-0702.
   Google Scholar
• Nier A, Brandt A, Conzelmann IB, Ozel Y, Bergheim I. Non-alcoholic fatty liver disease in overweight children: role of fructose intake and dietary pattern. Nutrients. 2018;10:1329. doi:https://doi.org/10.3390/nu10091329.
   Google Scholar
• Arslan N. Obesity, fatty liver disease and intestinal microbiota. World J Gastroenterol. 2014;20:16452–16463. doi:https://doi.org/10.3748/wjg.v20.i44.16452.
   Google Scholar
• Seki K, Kitade M, Nishimura N, Kaji K, Asada K, Namisaki T, Moriya K, Kawaratani H, Okura Y, Takaya H, et al. Oral administration of fructose exacerbates liver fibrosis and hepatocarcinogenesis via increased intestinal permeability in a rat steatohepatitis model. Oncotarget. 2018;9:28638–28651. doi:https://doi.org/10.18632/oncotarget.25587.
   Google Scholar
• Kinoshita Y, Ishimura N, Ishihara S. Advantages and disadvantages of long-term proton pump inhibitor use. J Neurogastroenterol Motil. 2018;24:182–196. doi:https://doi.org/10.5056/jnm18001.
   Google Scholar
• Wallace JL, Syer S, Denou E, de Palma G, Vong L, McKnight W, Jury J, Bolla M, Bercik P, Collins SM. Proton pump inhibitors exacerbate NSAID-induced small intestine injury by inducing dysbiosis. Gastroenterology. 2011;141:1314–1322. doi:https://doi.org/10.1053/j.gastro.2011.06.075.
   Google Scholar
• Suzuki T, Masui A, Nakamura J, Shiozawa H, Aoki J, Nakae H, Tsuda S, Imai J, Hideki O, Matsushima M, et al. Yogurt containing Lactobacillus gasseri mitigates aspirin-induced small bowel injuries: A prospective, randomized, double-blind, placebo-controlled trial. Digestion. 2017;95:49–54. doi:https://doi.org/10.1159/000452361.
   Google Scholar
• Endo H, Higurashi T, Hosono K, Sakai E, Sekino Y, Iida H, Sakamoto Y, Koide T, Takahashi H, Yoneda M, et al. Efficacy of Lactobacillus casei treatment on small bowel injury in chronic low-dose aspirin users: a pilot randomized controlled study. J Gastroenterol. 2011;46:894–905. doi:https://doi.org/10.1007/s00535-011-0410-1.
   Google Scholar
• Kawahara T, Makizaki Y, Oikawa Y, Tanaka Y, Maeda A, Shimakawa M, Komoto S, Moriguchi K, Ohno H, Taniguchi K. Oral administration of Bifidobacterium bifidum G9-1 alleviates rotavirus gastroenteritis through regulation of intestinal homeostasis by inducing mucosal protective factors. PLoS One. 2017;12:e0173979. doi:https://doi.org/10.1371/journal.pone.0173979.
   Google Scholar
• Amagase K, Murakimi T, Imasato A, Takemoto S, Tanaka R, Kato S, Takeuchi K. Beneficial effect of probiotic preparations on loxoprofen-induced small intestinal lesions in rats. Jpn Pharmacol Ther. 2014;42:581–589.
   Google Scholar
• Taupin D, Podolsky DK. Trefoil factors: initiators of mucosal healing. Nat Rev Mol Cell Biol. 2003;4:721–732. doi:https://doi.org/10.1038/nrm1203.
   Google Scholar
• Mashimo M, Wu DC, Podolsky DK, Fishman MC. Impaired defense of intestinal mucosa in mice lacking intestinal trefoil factor. Science. 1996;274:262–265. doi:https://doi.org/10.1126/science.274.5285.262.
   Google Scholar
• Ahrne S, Hagslatt ML. Effect of lactobacilli on paracellular permeability in the gut. Nutrients. 2011;3:104–117. doi:https://doi.org/10.3390/nu3010104.
   Google Scholar
• Derrien M, Vaughan EE, Plugge CM, de Vos WM. Akkermansia muciniphila gen. nov., sp. nov., a human intestinal mucin-degrading bacterium. Int J Syst Evol Microbiol. 2004;54:1469–1476. doi:https://doi.org/10.1099/ijs.0.02873-0.
   Google Scholar
• Shattuck-Brandt RL, Varilek GW, Radhika A, Yang F, Washington MK, DuBois RN. Cyclooxygenase 2 expression is increased in the stroma of colon carcinomas from IL-10(-/-) mice. Gastroenterology. 2000;118:337–345. doi:https://doi.org/10.1016/S0016-5085(00)70216-2.
   Google Scholar
• Kurokouch K, Kambe F, Yasukawa K, Izumi R, Ishiguro N, Iwata H, Seo H. TNF-alpha increases expression of IL-6 and ICAM-1 genes through activation of NF-kappaB in osteoblast-like ROS17/2.8 cells. J Bone Min Res. 1998;13:1290–1299. doi:https://doi.org/10.1359/jbmr.1998.13.8.1290.
   Google Scholar
• Yamamoto M, Yamazaki S, Uematsu S, Sato S, Hemmi H, Hoshino K, Kaisho T, Kuwata H, Tateuchi O, Takeshige K, et al. Regulation of Toll/IL-1-receptor-mediated gene expression by the inducible nuclear protein IkappaBzeta. Nature. 2004;430:218–222. doi:https://doi.org/10.1038/nature02738.
   Google Scholar
• Day RO, Graham GG. Non-steroidal anti-inflammatory drugs (NSAIDs). BMJ. 2013;346:f3195. doi:https://doi.org/10.1136/bmj.f1164.
   Google Scholar
• Watari I, Oka S, Tanaka S, Igawa A, Nakano M, Aoyama T, Yoshida S, Chayama K. Comparison of small-bowel mucosal injury between low-dose aspirin and non-aspirin non-steroidal anti-inflammatory drugs: a capsule endoscopy study. Digestion. 2014;89:225–231. doi:https://doi.org/10.1159/000358287.
   Google Scholar
• Nonoyama K, Nakagawa K, Amagase K, Takeuchi K, Nakamura M, Okabe S. New method of inducing intestinal lesions in rats by intraduodenal administration of aspirin. J Gastroenterol Hepatol. 2010;25:S15–22. doi:https://doi.org/10.1111/j.1440-1746.2010.06227.x.
   Google Scholar
• Lai Y, Zhong W, Yu T, Xia XS, Li JY, Ouyang H, Shan TD, Yang HS, Chen QK. Rebamipide promotes the regeneration of aspirin-induced small-intestine mucosal injury through accumulation of β-Catenin. PLoS One. 2015;10:e0132031. doi:https://doi.org/10.1371/journal.pone.0132031.
   Google Scholar
• Arakawa T, Watanabe T, Tanigawa T, Tomonaga K, Otani K, Nadatani Y, Fujiwara Y. Small intestine injury caused by NSAIDs/aspirin: finding new from old. Curr Med Chem. 2012;19:77–81. doi:https://doi.org/10.2174/092986712803414105.
   Google Scholar
• Watanabe T, Higuchi K, Kobata A, Nishio H, Tanigawa T, Shiba M, Tominaga K, Fujiwara Y, Oshitani N, Asahara T, et al. Non-steroidal anti-inflammatory drug-induced small intestinal damage is Toll-like receptor 4 dependent. Gut. 2008;57:181–187. doi:https://doi.org/10.1136/gut.2007.125963.
   Google Scholar
• Hojo M, Asahara T, Nagahara A, Takeda T, Matsumoto K, Ueyama H, Matsumoto K, Asaoka D, Takahashi T, Nomoto K, et al. Gut microbiota composition before and after use of proton pump inhibitors. Dig Dis Sci. 2018;63:2940–2949. doi:https://doi.org/10.1007/s10620-018-5122-4.
   Google Scholar
• Shin CM, Kim N, Kim YS, Nam RH, Park JH, Lee DH, Seok YJ, Kim YR, Kim JH, Kim JM, et al. Impact of long-term proton pump inhibitor therapy on gut microbiota in F344 Rats: pilot study. Gut Liver. 2016;10:896–901. doi:https://doi.org/10.5009/gnl15529.
   Google Scholar
• Jackson MA, Goodrich JK, Maxan ME, Freedberg DE, Abrams JA, Poole AC, Sutter JL, Welter D, Ley RE, Bell JT, et al. Proton pump inhibitors alter the composition of the gut microbiota. Gut. 2016;65:749–756. doi:https://doi.org/10.1136/gutjnl-2015-310861.
   Google Scholar
• Imhann F, Bonder MJ, Vich Vila A, Fu J, Mujagic Z, Vork L, Tigchelaar EF, Jankipersadsing SA, Cenit MC, Harmsen HJ, et al. Proton pump inhibitors affect the gut microbiome. Gut. 2016;65:740–748. doi:https://doi.org/10.1136/gutjnl-2015-310376.
   Google Scholar
• Gnauck A, Lentle RG, Kruger MC. The characteristics and function of bacterial lipopolysaccharides and their endotoxic potential in humans. Int Rev Immunol. 2016;35:189–218. doi:https://doi.org/10.3109/08830185.2015.1087518.
   Google Scholar
• Nygard G, Hudson M, Mazure G, Anthony A, Dhillon AP, Pounder RE, Wakefield AJ. Procoagulant and prothrombotic responses of human endothelium to indomethacin and endotoxin in vitro. Relevance to non-steroidal anti-inflammatory drug enteropathy. Scand J Gastroenterol. 1995;30:25–32. doi:https://doi.org/10.3109/00365529509093231.
   Google Scholar
• Zhu W, Gregory JC, Org E, Buffa JA, Gupta N, Wang Z, Li L, Fu X, Wu Y, Mehrabian M, et al. Gut Microbial Metabolite TMAO Enhances Platelet Hyperreactivity and Thrombosis Risk. Cell. 2016;165:111–124. doi:https://doi.org/10.1016/j.cell.2016.02.011.
   Google Scholar
• Desai MS, Seekatz AM, Koropatkin NM, Kamada N, Hickey CA, Wolter M, Pudlo NA, Kitamoto S, Terrapon N, Muller A. A Dietary Fiber-Deprived Gut Microbiota Degrades the Colonic Mucus Barrier and Enhances Pathogen Susceptibility. Cell. 2016;167:1339–1353. doi:https://doi.org/10.1016/j.cell.2016.10.043.
   Google Scholar
• Sands SA, Tsau S, Yankee TM, Parker BL, Ericsson AC, LeVine SM. The effect of omeprazole on the development of experimental autoimmune encephalomyelitis in C57BL/6J and SJL/J mice. BMC Res Notes. 2014;7:605. doi:https://doi.org/10.1186/1756-0500-7-605.
   Google Scholar
• Mangin I, Dossou-Yovo F, Leveque C, Dessoy MV, Sawoo O, Suau A, Pochart P. Oral administration of viable Bifidobacterium pseudolongum strain Patronus modified colonic microbiota and increased mucus layer thickness in rat. FEMS Microbiol Ecol. 2018;94:10. doi:https://doi.org/10.1093/femsec/fiy177.
   Google Scholar
• Plovier H, Everard A, Druart C, Depommier C, Van Hul M, Geurts L, Chilloux J, Ottman N, Duparc T, Lichtenstein L, et al. A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice. Nat Med. 2017;23:107–113. doi:https://doi.org/10.1038/nm.4236.
   Google Scholar
• Derrien M, Belzer C, de Vos WM. Akkermansia muciniphila and its role in regulating host functions. Microb Pathog. 2017;106:171–181. doi:https://doi.org/10.1016/j.micpath.2016.02.005.
   Google Scholar
• Hänninen A, Toivonen R, Pöysti S, Belzer C, Plovier H, Ouwerkerk JP, Emani R, Cani PD, De Vos WM. Akkermansia muciniphila induces gut microbiota remodelling and controls islet autoimmunity in NOD mice. Gut. 2018;67:1445–1453. doi:https://doi.org/10.1136/gutjnl-2017-314508.
   Google Scholar
• Anna E, Andre S, Malin EVJ, Jenny KG, Gunnar CH. Studies of mucus in mouse stomach, small intestine, and colon. I. Gastrointestinal mucus layers have different properties depending on location as well as over the Peyer’s patches. Am J Physiol Gastrointest Liver Physiol. 2013;305:G341–G347. doi:https://doi.org/10.1152/ajpgi.00046.2013.
   Google Scholar
• Everard A, Aron-Wisnewsky J, Sokolovska N, Prifti E, Verger EO, Kayser BD, Levenez F, Chilloux J, Hoyles L, Dumas ME, et al. Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity: relationship with gut microbiome richness and ecology. Gut. 2016;65:426–436. doi:https://doi.org/10.1136/gutjnl-2014-308778.
   Google Scholar
• Aamann L, Vestergaard EM, Grønbæk H. Trefoil factors in inflammatory bowel disease. World J Gastroenterol. 2014;20:3223–3230. doi:https://doi.org/10.3748/wjg.v20.i12.3223.
   Google Scholar
• Fornai M, Antonioli L, Colucci R, Pellegrini C, Giustarini G, Testai L, Martelli A, Matarangasi A, Natale G, Calderone V, et al. NSAID-Induced Enteropathy: Are the Currently Available Selective COX-2 Inhibitors All the Same? J Pharmacol Exp Ther. 2014;348:86–95. doi:https://doi.org/10.1124/jpet.113.207118.
   Google Scholar
• Tanaka A, Hase S, Miyazawa T, Ohno R, Takeuchi K. Role of cyclooxygenase (COX)-1 and COX-2 inhibition in nonsteroidal anti-inflammatory drug-induced intestinal damage in rats: relation to various pathogenic events. J Pharmacol Exp Ther. 2002;303:1248–1254. doi:https://doi.org/10.1124/jpet.102.041715.
   Google Scholar
• Smelt MJ, de Haan BJ, Bron PA, van Swam I, Meijerink M, Wells JM, Kleerebezem M, Faas MM, de Vos P. The impact of Lactobacillus plantarum WCFS1 teichoic acid D-Alanylation on the generation of effector and regulatory T-cells in healthy mice. PLoS One. 2013;8:e63099. doi:https://doi.org/10.1371/journal.pone.0063099.
   Google Scholar
• Macho FE, Valenti V, Rockel C, Hermann C, Pot B, Boneca IG, Grangette C. Anti-inflammatory capacity of selected lactobacilli in experimental colitis is driven by NOD2-mediated recognition of a specific peptidoglycan-derived muropeptide. Gut. 2011;60:1050–1059. doi:https://doi.org/10.1136/gut.2010.232918.
   Google Scholar
• Smith PM, Howitt MR, Panikov N, Michaud M, Gallini CA, Bohlooly YM, Glickman JN, Garrett WS. The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science. 2013;341:569–573. doi:https://doi.org/10.1126/science.1241165.
   Google Scholar
• Fukuda S, Toh H, Hase K, Oshima K, Nakanishi Y, Yoshimura K, Tobe T, Clarke JM, Topping DL, Suzuki T, et al. Bifidobacteria can protect from enteropathogenic infection through production of acetate. Nature. 2011;469:543–547. doi:https://doi.org/10.1038/nature09646.
   Google Scholar
• Liu Y, Alookaran JJ, Rhoads JM. Probiotics in autoimmune and inflammatory disorders. Nutrient. 2018;10:1537. doi:https://doi.org/10.3390/nu10101537.
   Google Scholar
• Li MO, Flavell RA. TGF-β: A master of all T cell trades. Cell. 2008;134:392–404. doi:https://doi.org/10.1016/j.cell.2008.07.025.
   Google Scholar
• Makizaki Y, Maeda A, Oikawa Y, Tamura S, Tanaka Y, Nakajima S, Yamamura H. Alleviation of low-fiber diet-induced constipation by probiotic Bifidobacterium bifidum G9-1 is based on correction of gut microbiota dysbiosis. Biosci Microbiota Food Health. 2019;38:49–53. doi:https://doi.org/10.12938/bmfh.18-020.
   Google Scholar
• Rivière A, Selak M, Lantin D, Leroy F, De Vuyst L. Bifidobacteria and Butyrate-Producing Colon Bacteria: Importance and Strategies for Their Stimulation in the Human Gut. Front Microbiol. 2016;7:979. doi:https://doi.org/10.3389/fmicb.2016.00979.
   Google Scholar
• Chiu CJ, McArdle AH, Brown R, Scott HJ, Gurd FN. Intestinal mucosal lesion in low-flow states. I. A morphological, hemodynamic and metabolic reappraisal. Arch Surg. 1970;101:478–483. doi:https://doi.org/10.1001/archsurg.1970.01340280030009.
   Google Scholar
• Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch S, Preibisch S, Rueden C, Saalfeld S, Schmid B, et al. Fiji: an open-source platform for biological-image analysis. Nat Methods. 2012;9:676–682. doi:https://doi.org/10.1038/nmeth.2019.
   Google Scholar
• Mizuno M, Noto D, Kaga N, Chiba A, Miyake S. The dual role of short fatty acid chains in the pathogenesis of autoimmune disease models. PLoS One. 2017;12:e0173032. doi:https://doi.org/10.1371/journal.pone.0173032.
   Google Scholar
• Lefrançois L, Lycke N. Isolation of mouse small intestinal intraepithelial lymphocytes, Peyer’s patch, and lamina propria cells. Curr Protoc Immunol. 2001;Chapter 3:Unit 3.19.
   Google Scholar
• Matsuki T, Watanabe K, Fujimoto J, Takada T, Tanaka R. Use of 16S rRNA gene-targeted group-specific primers for real-time PCR analysis of predominant bacteria in human feces. Appl Environ Microbiol. 2004;70:7220–7228. doi:https://doi.org/10.1128/AEM.70.12.7220-7228.2004.
   Google Scholar
• Fadrosh DW, Ma B, Gajer P, Sengamalay N, Ott S, Brotman RM, Ravel L. An improved dual-indexing approach for multiplexed 16S rRNA gene sequencing on the Illumina MiSeq platform. Microbiome. 2014;2:6. doi:https://doi.org/10.1186/2049-2618-2-6.
   Google Scholar
• Caporaso JG, Kuczynski J, Stombaugh J, Bittinger K, Bushman FD, Costello EK, Fierer N, Pena AG, Goodrich JK, Gordon JI, et al. QIIME allows analysis of high-throughput community sequencing data. Nat Methods. 2010;27:335–336. doi:https://doi.org/10.1038/nmeth.f.303.
   Google Scholar
• Fukui H, Oshima T, Tanaka Y, Oikawa Y, Makizaki Y, Ohno H, Tomita T, Watari J, Miwa H. Effect of probiotic Bifidobacterium bifidum G9-1 on the relationship between gut microbiota profile and stress sensitivity in maternally separated rats. Sci Rep. 2018;8:12384. doi:https://doi.org/10.1038/s41598-018-30943-3.
   Google Scholar
• Kim SW, Suda W, Kim S, Oshima K, Fukuda S, Ohno H, Morita H, Hattori M. Robustness of gut microbiota of healthy adults in response to probiotic intervention revealed by high-throughput pyrosequencing. DNA Res. 2013;20:241–253. doi:https://doi.org/10.1093/dnares/dst006.
   Google Scholar
• Lozupone C, Knight R. UniFrac: a new phylogenetic method for comparing microbial communities. Appl Environ Microbiol. 2005;71:8228–8235. doi:https://doi.org/10.1128/AEM.71.12.8228-8235.2005.
   Google Scholar
• Kanda Y. Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transplant. 2013;48:452–458. doi:https://doi.org/10.1038/bmt.2012.244.
   Google Scholar